A hydrogel platform technology
Oxford Medical Products has developed a proprietary gastroretentive hydrogel platform that enables new approaches to treating obesity and delivering medicines. This technology forms the foundation of our two core assets:
Sirona: A non-pharmacological treatment designed to help people manage overweight and obesity.
OMP GEL: A drug delivery platform that enables the controlled delivery of small molecules and biologics.
The technology has other potential applications in nutraceutical delivery and biosensors.
Partnering
We partner with drug developers to deliver their APIs using our hydrogel-based long-term gastroretentive drug delivery system.
